Article

Highlights Expected at the 2012 Consortium of Multiple Sclerosis Centers Annual Meeting

HCPLive will be providing live coverage from the 2012 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting in cooperation with Americans Committe for Treatment and Research in Multiple Sclerosis (ACTRIMS). Here are some of the highlights to look forward to during the meeting.

HCPLive will be providing live coverage from the 2012 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting in cooperation with Americans Committe for Treatment and Research in Multiple Sclerosis (ACTRIMS) from May 30-June 3.

The focus of this meeting is to provide health care professionals who treat patients with multiple sclerosis up-to-date information in the areas of research, disease modification, epidemiology, symptomatic management, pathophysiology, neuroimaging, quality of life, rehabilitation, psychosocial support, MS collaborative care, gender specific issues, new and emerging therapies, and biomarkers.

Highlighted sessions at the conference include:

May 30, 2012Personalized Medicine in Multiple Sclerosis: Examining the Path Forward

10:00AM - 11:30AM

Speakers: Fred D. Lublin, MD, FAAN, Chair; Robert P. Lisak, MD, FRCP, FAAN; Lawrence Steinman, MD

Use of Functional Electrical Stimulation (FES) in MS Gait: Psychologic Prinicples, Clinical Application, Evidence & Outcomes of Dropped Foot Stimulation to Improve Walking in the MS Patient

2:15PM-3:45PM

Speaker: Maura Whittaker, BSc, PT

May 31, 2012

Antibodies in MS

9:00AM - 12:00PM

Speakers: Lawrence Steinman, MD, Chair; Stephen Hauser, MD; Scott Zamvil, MD, PhD; Joanne Jones, MD

Topics to be discussed include:

  • Introduction-Monoclonals in MS-Successes and Failures
  • Anti-CD20 in RRMS
  • Mechanism of Action of anti-CD20 Therapy in Multiple Sclerosis
  • Anti-CD52 in RRMS, Biomarkers, Mechanism of Action

Infectious Complications of MS Therapies

3:15PM - 5:15PM

Speakers: Subhayl Dhib-Jalbut, MD, Chair; Olaf Stuve, MD; Paul O'Connor, MD, MSc, FRCPC; David Clifford, MD

Topics to be discussed include:

  • Introduction and Overview of Infectious Complications
  • Pathological and Mechanistic Aspects of PML and IRIS
  • JCV-PML Risk Stratification
  • Pre-clinical Detection and Management of PML

Click here to review additional symposias and workshops being presented throughout the duration of the meeting.

Related Videos
Ashfaq Marghoob, MD: Artificial Intelligence, Smartphone Use for Pigmented Lesion Classification
Steve Nissen, MD | Credit: Cleveland Clinic
Major Diagnostic Challenges for Pigmented Lesions, with Ashfaq Marghoob, MD
Sherona Bau, NP | Credit: UCLA Health
Jessica Crimaldi, NP | Credit: Jessica Crimaldi on LinkedIn
Benjamin Scirica, MD | Credit: Brigham and Women's Hospital
© 2024 MJH Life Sciences

All rights reserved.